Carta científico-clínica
Análisis de coste-eficacia incremental de los tratamientos biológicos para la psoriasis en los momentos de valoración significativos para la práctica clínica
Incremental Cost-Effectiveness Ratio Analysis of Biologic Treatments for Psoriasis at Clinically Significant Evaluation Time Points
L. Puig
, A. López-Ferrer, E. Vilarrasa
Autor para correspondencia
Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, España
Leído
13936
Vecesse ha leído el artículo
2704
Total PDF
11232
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 222 | 27 | 249 |
| 2025 5 | 236 | 35 | 271 |
| 2025 4 | 271 | 18 | 289 |
| 2025 3 | 305 | 18 | 323 |
| 2025 2 | 259 | 23 | 282 |
| 2025 1 | 227 | 28 | 255 |
| 2024 12 | 322 | 26 | 348 |
| 2024 11 | 293 | 42 | 335 |
| 2024 10 | 204 | 48 | 252 |
| 2024 9 | 202 | 28 | 230 |
| 2024 8 | 189 | 57 | 246 |
| 2024 7 | 245 | 28 | 273 |
| 2024 6 | 245 | 31 | 276 |
| 2024 5 | 209 | 32 | 241 |
| 2024 4 | 242 | 30 | 272 |
| 2024 3 | 224 | 38 | 262 |
| 2024 2 | 177 | 28 | 205 |
| 2024 1 | 278 | 18 | 296 |
| 2023 12 | 274 | 14 | 288 |
| 2023 11 | 340 | 38 | 378 |
| 2023 10 | 189 | 30 | 219 |
| 2023 9 | 182 | 29 | 211 |
| 2023 8 | 141 | 16 | 157 |
| 2023 7 | 172 | 37 | 209 |
| 2023 6 | 199 | 31 | 230 |
| 2023 5 | 245 | 36 | 281 |
| 2023 4 | 208 | 35 | 243 |
| 2023 3 | 149 | 28 | 177 |
| 2023 2 | 164 | 27 | 191 |
| 2022 1 | 138 | 48 | 186 |
| 2022 12 | 143 | 33 | 176 |
| 2022 11 | 225 | 41 | 266 |
| 2022 10 | 170 | 41 | 211 |
| 2022 9 | 134 | 57 | 191 |
| 2022 8 | 129 | 80 | 209 |
| 2022 7 | 165 | 82 | 247 |
| 2022 6 | 145 | 29 | 174 |
| 2022 5 | 166 | 54 | 220 |
| 2022 4 | 106 | 40 | 146 |
| 2022 3 | 96 | 49 | 145 |
| 2022 2 | 104 | 37 | 141 |
| 2021 1 | 149 | 46 | 195 |
| 2021 12 | 127 | 44 | 171 |
| 2021 11 | 144 | 56 | 200 |
| 2021 10 | 132 | 58 | 190 |
| 2021 9 | 87 | 33 | 120 |
| 2021 8 | 90 | 23 | 113 |
| 2021 7 | 148 | 43 | 191 |
| 2021 6 | 92 | 47 | 139 |
| 2021 5 | 80 | 36 | 116 |
| 2021 4 | 119 | 72 | 191 |
| 2021 3 | 105 | 21 | 126 |
| 2021 2 | 61 | 26 | 87 |
| 2020 1 | 52 | 31 | 83 |
| 2020 12 | 47 | 21 | 68 |
| 2020 11 | 48 | 17 | 65 |
| 2020 10 | 51 | 18 | 69 |
| 2020 9 | 48 | 13 | 61 |
| 2020 8 | 37 | 24 | 61 |
| 2020 7 | 35 | 6 | 41 |
| 2020 6 | 39 | 19 | 58 |
| 2020 5 | 48 | 25 | 73 |
| 2020 4 | 35 | 17 | 52 |
| 2020 3 | 29 | 25 | 54 |
| 2020 2 | 2 | 3 | 5 |
| 2020 1 | 7 | 3 | 10 |
| 2019 12 | 8 | 6 | 14 |
| 2019 11 | 4 | 1 | 5 |
| 2019 10 | 0 | 3 | 3 |
| 2019 9 | 4 | 3 | 7 |
| 2019 8 | 4 | 6 | 10 |
| 2019 7 | 4 | 2 | 6 |
| 2019 6 | 4 | 13 | 17 |
| 2019 5 | 7 | 7 | 14 |
| 2019 4 | 2 | 20 | 22 |
| 2019 3 | 11 | 8 | 19 |
| 2019 2 | 2 | 4 | 6 |
| 2019 1 | 3 | 3 | 6 |
| 2018 12 | 2 | 3 | 5 |
| 2018 11 | 2 | 1 | 3 |
| 2018 10 | 3 | 3 | 6 |
| 2018 9 | 3 | 1 | 4 |
| 2018 8 | 0 | 3 | 3 |
| 2018 7 | 0 | 5 | 5 |
| 2018 6 | 0 | 4 | 4 |
| 2018 5 | 0 | 8 | 8 |
| 2018 4 | 0 | 4 | 4 |
| 2018 3 | 2 | 4 | 6 |
| 2018 2 | 38 | 12 | 50 |
| 2018 1 | 53 | 15 | 68 |
| 2017 12 | 64 | 12 | 76 |
| 2017 11 | 70 | 17 | 87 |
| 2017 10 | 66 | 13 | 79 |
| 2017 9 | 40 | 16 | 56 |
| 2017 8 | 60 | 8 | 68 |
| 2017 7 | 34 | 22 | 56 |
| 2017 6 | 81 | 24 | 105 |
| 2017 5 | 45 | 11 | 56 |
| 2017 4 | 40 | 10 | 50 |
| 2017 3 | 41 | 22 | 63 |
| 2017 2 | 26 | 15 | 41 |
| 2016 1 | 31 | 17 | 48 |
| 2016 12 | 48 | 19 | 67 |
| 2016 11 | 15 | 7 | 22 |
| 2016 10 | 5 | 5 | 10 |
| 2016 9 | 1 | 8 | 9 |
| 2016 8 | 1 | 7 | 8 |
| 2016 7 | 6 | 3 | 9 |
| 2016 6 | 14 | 3 | 17 |
| 2016 5 | 6 | 21 | 27 |
| 2016 4 | 10 | 3 | 13 |
| 2016 3 | 7 | 1 | 8 |
| 2016 2 | 12 | 1 | 13 |
| 2015 1 | 11 | 1 | 12 |
| 2015 12 | 10 | 1 | 11 |
| 2015 11 | 10 | 1 | 11 |
| 2015 10 | 20 | 19 | 39 |
| 2015 9 | 15 | 3 | 18 |
| 2015 8 | 27 | 1 | 28 |
| 2015 7 | 21 | 2 | 23 |
| 2015 6 | 21 | 7 | 28 |
| 2015 5 | 5 | 8 | 13 |
| 2015 4 | 11 | 17 | 28 |
| 2015 3 | 24 | 12 | 36 |
| 2015 2 | 18 | 12 | 30 |
| 2015 1 | 5 | 7 | 12 |
| 2014 12 | 7 | 15 | 22 |
| 2014 11 | 2 | 0 | 2 |
Mostrar todo
